Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism

Cindy M.M. de Jong, Chantal Visser, Remy H.H. Bemelmans, Wim Boersma, Bram van den Borst, Jacobus Burggraaf, Suzanne C. Cannegieter, Arina J. ten Cate‐Hoek, F. Nanne Croles, Harald J. Faber, Laura M. Faber, Merel E. Hellemons, Lisa Hessels, Menno V. Huisman, Pieter W. Kamphuisen, Stephanie C. E. Koster, Lucia J.M. Kroft, Ivo van der Lee, Jenneke Leentjens, Karina Meijer, Maarten K. Ninaber, Brigitte M. Sondermeijer, Susanne Stads, Anton Vonk Noordegraaf, Kristien Winckers, Marieke J. H. A. Kruip, Frederikus A. Klok

2023European Respiratory Journal20 citationsDOI Open Access PDF

Abstract

<b>The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE</b> https://bit.ly/3IjvWL3

Topics & Concepts

MedicinePulmonary embolismCoronavirus disease 2019 (COVID-19)ThrombusComplicationCardiologyInternal medicinePulmonary hypertensionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakChronic thromboembolic pulmonary hypertensionVirologyDiseaseOutbreakInfectious disease (medical specialty)Venous Thromboembolism Diagnosis and ManagementLong-Term Effects of COVID-19Cardiovascular Disease and Adiposity